Schizophrenia.com

Alkermes to seek schizophrenia drug approval after trial success

#1

Alkermes Plc said it planned to seek U.S. marketing approval for its experimental drug to treat the symptoms of schizophrenia after it succeeded in a late-stage study, sending the company’s shares up as much as 11 percent.

The company said it would apply for marketing approval for a monthly dose of the injectable drug, aripiprazole lauroxil, in the third quarter of 2014.

1 Like

#2

Is this resperidol?**

0 Likes

#3

No - long acting Abilify. This company develops the long acting version of these medicines:
http://www.alkermes.com/Products

0 Likes